BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing, manufacturing and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases. BiondVax is a publicly traded company, listed on the Nasdaq.